Rising Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for RISING, and what generic and branded alternatives to RISING drugs are available?
RISING has one hundred and ninety-four approved drugs.
Drugs and US Patents for Rising
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rising | ZOLMITRIPTAN | zolmitriptan | TABLET, ORALLY DISINTEGRATING;ORAL | 202855-002 | Sep 20, 2019 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Rising | CLOPIDOGREL BISULFATE | clopidogrel bisulfate | TABLET;ORAL | 077665-001 | May 17, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Rising | OLMESARTAN MEDOXOMIL | olmesartan medoxomil | TABLET;ORAL | 078276-001 | Oct 26, 2016 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Rising | NIACIN | niacin | TABLET, EXTENDED RELEASE;ORAL | 203742-003 | Feb 22, 2019 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Rising
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Rising | SULFAMYLON | mafenide acetate | CREAM;TOPICAL | 016763-001 | Approved Prior to Jan 1, 1982 | 3,497,599 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.